Skip to main content
Premium Trial:

Request an Annual Quote

Covaris and Illumina to Co-Market Sample-Prep Tools, Sequencers

Premium

Covaris said this week that it has signed a co-marketing agreement with Illumina under which the companies will co-market Covaris' DNA shearing technology with Illumina's sequencing product line, including the Genome Analyzer, HiSeq 2000, and HiScanSQ.

Financial details of the deal were not disclosed.

The Covaris system is used to prepare samples for sequencing. According to the company, its technology "enables higher recoveries for nucleic acid extraction, tissue homogenization, chromatin shearing, protein digestion, and cell lysis."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more